Profile
Graham Watman was Executive Chairman of Grant
Thornton (Sydney) and is a non-executive Director
of a number of companies.
Former positions of Allan Graham Watman
Companies | Position | End |
---|---|---|
MANALTO LIMITED | Founder | 17/12/2007 |
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Cryptome Pharmaceuticals Ltd is a globally-linked, Melbourne-based biotechnology company created to discover and develop effective and safe protein-derived medicines targeting cancer, cardiovascular disease and chronic inflammatory disorders using a proprietary proteomics-based technology platform. | Director/Board Member | 05/04/2006 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Cryptome Pharmaceuticals Ltd.
Cryptome Pharmaceuticals Ltd. BiotechnologyHealth Technology Cryptome Pharmaceuticals Ltd is a globally-linked, Melbourne-based biotechnology company created to discover and develop effective and safe protein-derived medicines targeting cancer, cardiovascular disease and chronic inflammatory disorders using a proprietary proteomics-based technology platform. | Health Technology |
Manalto Ltd.
Manalto Ltd. Packaged SoftwareTechnology Services Manalto Ltd. engages in the development and commercialization of social media management software. It operates through the following geographical segments: Australia, USA, Ireland, South Africa, and the Netherlands. The company was founded by Gregory Edward Rice, Nick Gatsios, Anthony Owen and Allan Graham Watman on November 2, 2001 and is headquartered in Annangrove, Australia. | Technology Services |
- Stock Market
- Insiders
- Allan Graham Watman